Direkt zum Inhalt
Merck
Alle Fotos(1)

Key Documents

Weitere Dokumente

07-2980

Sigma-Aldrich

Diethylenglycolmonoethylether

SAJ first grade, ≥98.0%

Synonym(e):

CARBITOL™, Ethyldiglykol

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Lineare Formel:
C2H5OCH2CH2OCH2CH2OH
CAS-Nummer:
111-90-0
Molekulargewicht:
134.17
Beilstein:
1736441
EG-Nummer:
203-919-7
MDL-Nummer:
MFCD00002872
UNSPSC-Code:
12352112
PubChem Substanz-ID:
329748401

Qualität

SAJ first grade

Dampfdichte

4.63 (vs air)

Dampfdruck

0.12 mmHg ( 20 °C)

Assay

≥98.0%

Form

liquid

Expl.-Gr.

1.2 %, 135 °F
23.5 %, 182 °F

Verfügbarkeit

available only in Japan

Brechungsindex

n20/D 1.427 (lit.)

bp

202 °C (lit.)

Dichte

0.999 g/mL at 25 °C (lit.)

SMILES String

CCOCCOCCO

InChI

1S/C6H14O3/c1-2-8-5-6-9-4-3-7/h7H,2-6H2,1H3

InChIKey

XXJWXESWEXIICW-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Rechtliche Hinweise

CARBITOL is a trademark of The Dow Chemical Company or an affiliated company of Dow

Lagerklassenschlüssel

10 - Combustible liquids

WGK

WGK 1

Flammpunkt (°F)

204.8 °F - closed cup

Flammpunkt (°C)

96 °C - closed cup

Persönliche Schutzausrüstung

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Yousef Javadzadeh et al.
Colloids and surfaces. B, Biointerfaces, 82(2), 422-426 (2010-10-19)
Regarding the potential severe toxicity associated with systemic administration of methotrexate (MTX), a topical formulation might be of greater utility for the treatment of psoriasis and other hyperproliferative skin disorders. One of the presumed reasons for the lack of clinical
Liandong Hu et al.
International journal of pharmaceutics, 420(2), 251-255 (2011-09-13)
The objective of the present study was to formulate a microemulsion system for oral administration to improve the solubility and bioavailability of fenofibrate. Various formulations were prepared using different ratios of oils, surfactants and co-surfactants (S&CoS). Pseudo-ternary phase diagrams were
Dong Hoon Oh et al.
International journal of pharmaceutics, 420(2), 412-418 (2011-09-29)
In order to compare the effects of hydrophilic and hydrophobic solid carrier on the formation of solid self-microemulsifying drug delivery system (SMEDDS), two solid SMEDDS formulations were prepared by spray-drying the solutions containing liquid SMEDDS and solid carriers. Colloidal silica
Hyun-Jong Cho et al.
International journal of pharmaceutics, 423(2), 153-160 (2012-01-03)
To achieve rapid onset of action and improved bioavailability of udenafil, a microemulsion system was developed for its intranasal delivery. Phase behavior, particle size, transmission electron microscope (TEM) images, and the drug solubilization capacity of the microemulsion were investigated. A
Roberta Censi et al.
Drug development and industrial pharmacy, 38(9), 1128-1133 (2011-12-23)
A microemulsion for the cutaneous release of quercetin was prepared. An aqueous phase, containing 40% Transcutol® P as solubilizing agent and permeation enhancer, was emulsified with Labrafil® as oil phase and Labrasol®/Capryol™ 90 as Solvent/Co-solvent. Quercetin was dissolved in the
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.